Antara Capital LP Intercept Pharmaceuticals, Inc. Transaction History

Antara Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $1.62 Million - $3.17 Million	-83,926 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $2.05 Million - $3.56 Million	83,926 New	83,926 $2.07 Million
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $1.15 Million - $2.81 Million	-23,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $1.36 Million - $2.94 Million	23,700 New	23,700 $2.94 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

Stay updated on Antara Capital LP with notifications on news.